Background: Especially in hidden lesions causing drug-resistant frontal lobe epilepsy (FLE), the localization of the epileptic zone EZ can be a challenge. Magnetoencephalography (MEG) can raise the chances for localization of the (EZ) in combination with electroencephalography (EEG). We investigated the impact of MEG-guided epilepsy surgery with the aid of neuronavigation and intraoperative MR imaging (iopMRI) on seizure outcome of FLE patients. Methods: Twenty-eight patients (15 females, 13 males; mean age 31.0 ± 11.1 years) underwent surgery in our department. All patients underwent presurgical MEG monitoring (two-sensor Magnes II or whole head WH3600 MEG system; 4-D Neuroimaging, San Diego, CA, USA). Of those, six patients (group 1) with MRI-negative FLE were operated on before 2002 with intraoperative electrocorticography (ECoG) and invasive EEG mapping only. Eleven patients with MRI-negative FLE (group 2) and eleven with lesional FLE (group 3) underwent surgery using 1.5 T-iopMRI and neuronavigation, including intraoperative visualization of the MEG localizations in 22 and functional MR imaging (for motor and speech areas) as well as DTI fiber tracking (for language and pyramidal tracts) in 13 patients. Results: In the first group, complete resection of the defined EZ including the MEG localization according to the latest postoperative MRI was achieved in four out of six patients. Groups two and three had complete removal of the MEG localizations in 20/22 (91%, 10 of 11 each). Intraoperative MRI revealed incomplete resection of the MEG localizations of four patients (12%; two in both groups), leading to successful re-resection. Transient and permanent neurological deficits alike occurred in 7.1%, surgeryassociated complications in 11% of all patients. In the first group, excellent seizure outcome (Engel Class IA) was achieved in three (50%), in the second in 7 patients (61%) and third group in 8 patients (64%, two iopMRI-based re-resections). Mean follow-up was 70.3 months (from 12 to 284 months). Conclusion: In our series, MEG-guided resection using neuronavigation and iopMR imaging led to promising seizure control rates. Even in non-lesional FLE, seizure control rates and the probability of complete resection of the MEG localizations was similar to lesional FLE using multimodal navigation.
Introduction
Approximately 25-40% of patients with epilepsy suffer from drug-resistant seizures. Besides the disabling occurrence of seizures, patients experience cognitive impairment, reduced quality of life, increased mortality and permanent neurological deficits when not treated surgically (Laxer et al., 2014) . Following tem-Seizure control rates drop dramatically to 21.1%-32.7% in those patients with MRI-negative FLE (Englot et al., 2012) .
One approach to deal with this type of epilepsy contains the application of additional non-invasive diagnostic methods. Especially in non-lesional, ill-defined cases, magnetoencephalography (MEG) provides additional information and guidance and is complimentarily used to electroencephalography(EEG)-techniques (De Tiège et al., 2012; Ossenblok et al., 2007; Stefan et al., 2011; Wu et al., 2013) . MEG is a useful tool to resolve discordant MRI and EEG data, which directly converts into a better seizure control in the long run (Funke et al., 2011; Wilenius et al., 2013) . Furthermore, in another study by Funke et al. (2011) , it led to the identification of a previously overlooked epileptic lesion in 7 of 40 patients (17.5%). Furthermore, it can be used for functional mapping, including language, primary sensory/motor cortex or visual field localization (Tovar-Spinoza et al., 2008) . Using intraoperative MRI and neuronavigation in extratemporal epilepsy surgery has many advantages, starting from intraoperative resection control and thus seizure control to minimizing postoperative neurological deficits, morbidity and mortality due to the safer resection margin displayed through the microscope (Sommer et al., 2013) . Incorporating additional functional data in neuronavigation, especially epileptic MEG clusters, is a logical development of those technical innovations (Tovar-Spinoza et al., 2008) .
In this study, we wanted to test the hypothesis if the use of intraoperative MR imaging and neuronavigation could improve the extent of resection as well as the rate of complete removal of epileptic MEG localizations. As results of lesional epilepsy surgery are known to be superior to ill-defined cases, we compared long term seizure control rates in patients with lesional and MRI-negative FLE in our center. Furthermore, the advantages and drawbacks of this sophisticated surgical approach and its possible benefit regarding seizure control are discussed.
Material and methods

Patients
From a total of 51 patients with frontal lobe epilepsy that underwent surgery in our department from March 2004 to February 2015, 22 patients were included in this retrospective analysis. Inclusion criteria were: (1) drug-resistant epilepsy, (2) frontal lobe localization of the epileptogenic zone, (3) lesional or MRI-negative pathology associated with epileptic activity (4) MEG recording and (5) application of intraoperative MRI and neuronavigation with visualization of the MEG cluster localizations. Furthermore, we included six additional patients treated without the use of iopMRI and neuronavigation which have been reported on earlier by our group (Mu et al., 2014; Wu et al., 2013) . Drug-resistant epilepsy had been defined according to the proposal by the International League Against Epilepsy (Kwan et al., 2010) . Each patient underwent an extensive presurgical epilepsy protocol that consisted of video-EEG monitoring, high-resolution 1.5-3 T MRI scanning and neuropsychological tests (e.g. WADA-test) to confirm hemispheric language dominance. All patients underwent invasive presurgical EEG-monitoring with implantation of subdural and/or depth electrodes. Additional investigations included 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and single photonemission computed tomography (SPECT) in selected patients. The diagnosis of FLE was established at the Center of Epilepsy, University Hospital Erlangen. Eloquent brain areas were identified by applying functional fMRI and DTI tractography.
Data acquisition and analysis
Magnetoencephalography (MEG)
Until 2001, only software provided by the MEG manufacturer (4D Neuroimaging, San Diego, CA, USA) was used for routine clinical analysis. The procedure utilized single moving dipoles which were calculated for samples above the noise (>approx. SNR 1.5-2) of the rising slope of individual spikes. A single compartment spherical volume conductor was used. The resulting dipoles were filtered according to quality criteria, such as correlation and confidence volume. In-house thresholds based on clinical experience were used and ranged for example between 0.95 and 0.99 for correlation and 3-5 cm 3 for confidence volumes. The high correlation thresholds are partially based on the reduced number of sensor with the Magnes II system (4D Neuroimaging, San Diego, CA, USA), which used two sensor units with only 37 channels each. These units were placed over regions of interest, however control regions were also investigated.
Starting in 2001, additional analysis was performed using Curry (version 4.6, with later upgrades to newer versions). The standard procedure included single moving dipoles and current density approaches of the rising slope of individual spikes in 3 spherical shell and boundary element model volume conductors. Comparable thresholds for quality criteria were utilized. These were adapted to the whole-head system (WHS 3600, 4D Neuroimaging, San Diego, CA, USA), which was installed in 2010.
Since 2013, BESA Research (version 6.0 and 6.1, BESA GmbH, Gräfeling, Germany) is used. BESA applies an approach which is based on averaging of spikes of similar morphology. The rationale is that this enables higher SNR and allows analysis of early components during spike onset. Regional dipoles at the onset and around the peak of the spike are fitted to test different hypotheses about origin and propagation of activity. The recommended procedure requires minimal interaction of the user and provides a standardized protocol. Dipole analysis is cross checked by calculating additional distributed approaches (CLARA, LORETA and/or Minimum-norm). Single compartment spherical volume conductors are used, distributed models are either calculated on a 3D grid or are constrained to the individual cortical surface.
Clustering, respectively focality of a localization was determined visually. If localizations from individual spikes were locally grouped and constrained to one or two gyri, they were considered focal. If the localizations showed a larger overall scattering, the term "diffuse" was used in the report. If several groups with larger distance between the respective localizations than within the individual groups occurred, they were described as multifocal or scattered. In case of averaged results, the same terminology was used. However, the criteria on which these were based had to be adapted, as averaged results do not provide clusters of localization. Instead, concordance between dipoles and distributed sources, as well as the amount of noise and explained variance and the spatial pattern of distributed sources were interpreted.
While the source analysis approach evolved over time, each variant was well defined and standardized. The localization results evaluated in this study were thus taken from the MEG reports and thus represent the exact result which was utilized for further clinical workup, planning of surgery and neuronavigation.
Intraoperative ECoG
All subjects underwent invasive phase II monitoring. Additionally, intraoperative ECoG with subsequent resection was applied in eight patients (Tables 1A and 1B) . We used either a combination of up to four 4-to 6-contact subdural strips, 4-contact depth electrodes for hippocampal and amygdala positioning, 32-electrode subdural grids (companies: Ad-Tech Medical Instrument Corporation, Racine, WI, U.S.A., and PMT/Permark Corporation, Chanhassen, MN, U.S.A.) as well as an electrode rack (Olivier et al., 2012) consisting of 16 surface electrodes. Correct anatomical position of the electrodes was confirmed by the first iopMRI scans. Intraoperative EEG was derived from the assumed epileptogenic zone (EZ) identified by presurgical evaluation in order to better define the margins of the resection and invasive subdural strip-, grid-and depth electrode monitoring.
Functional MR imaging and fiber tracking
The technical setup was reported in detail in previous publications of our group (Sommer et al., 2013) . In short, we used a 1.5-T MR clinical whole-body scanner with echo planar imaging (Magnetom Sonata, Siemens Medical Solutions, Erlangen, Germany) to acquire a T1-weighted 3D MPRAGE (magnetization prepared rapid acquisition gradient echo) dataset. Eloquent brain areas were identified using specific stimulation paradigms according to the individual cognitive abilities of each patient. Diffusion-tensor imaging (DTI) can display the orientation of axons in white matter as neuronal fiber tracts. We used a single-shot spin-echo diffusionweighted echo planar imaging (EPI) sequence to localize fiber bundles. We only used diffusion tensors with the main axis of direction having a minimum fiber length of 50 mm. After defining the starting and target regions, 3D-tractography was segmented and displayed in colour-encoded fractional anisotropy maps.
To finalize the preoperative functional navigation plan for resective surgery, epileptic MEG localizations were co-registered and subsequently, optimal trajectories to the defined resection extent and ideal size of craniotomy were planned ( Fig. 2 ) using iPlan neuronavigation software (Brainlab AG, Feldkirchen, Germany). The minimum distance of 5.6 ± 5.9 mm between the defined zone of resection and eloquent brain structures was measured manually using the "ruler"-function of the navigation software.
Intraoperative MRI
After putting the patient under general anesthesia, we performed a 1.5 T iopMRI in our BrainSuite TM (Magnetom Sonata Maestro Class, Siemens Healthcare, Erlangen, Germany) in order to acquire the first imaging data set. The intraoperative scan sequences included a T1-weighted MPRAGE sequence, T2-weighted transversal images and DTI sequences as reported before (Sommer et al., 2013) . We applied the same scanning protocol for all intraoperative MR images taken. Afterwards, the patient was rotated into the operating position. Preoperative functional data and intraoperative MRI data were co-registered using our neuronavigation software (iPlan 2.6, Brainlab AG, Feldkirchen, Germany). After transferring data transferred to the OPMI Pentero operation microscope (Zeiss, Oberkochen, Germany) and navigation system, referenciation followed. The co-registration of intraoperative MRI with anatomical structures was accomplished with a mean error of 1.7 ± 0.8 mm before surgery began.
Surgical technique
Epilepsy surgery in this series included corticotomies or extended lesionectomies where the surgeon had the impression to dissect pathological brain tissue (haptic perception/visual changes) despite the fact that pre-operative MRI showed no structural lesion. Keeping in mind the eloquent brain areas and fiber tracts, we kept close to the displayed structures and spared normal brain tissue. After we had the impression of complete resection of the defined epileptogenic zone according to our presurgical workup, we applied the first iopMRI control scan. In cases where the epileptic MEG localizations were not or only partially removed, we performed an update of neuronavigation data. Then, the patient was brought back in the operating position to continue with the re-resection. A final iopMRI scan confirmed complete resection of the MEG cluster localization before the closing procedure (Fig. 3) .
Postoperative neurological deterioration
Patients were examined before, immediately after surgery as well as three months post-surgery and at the most recent follow-up visit in the outpatients'. We defined mild neurological deterioriation in cases where quadrantanopsia, slight aphasia or latent monoparesis occurred. Patients who experienced complete hemianopsia, global aphasia or manifest paresis were classified as suffering from severe neurological deficits.
Epilepsy outcome
Seizure control was investigated using the Engel classification (Engel et al., 1993 ). An excellent seizure control was defined as Engel class IA, whereas a favourable outcome included Engelís classes I and II. The categories III and IV were assigned to the category poor seizure control.
Patients' most recent epilepsy outcome was obtained from the regular follow-up examinations at the Epilepsy Center of the University Hospital Erlangen and via telephone interviews.
Results
In total, we included 28 patients, which were divided in three groups. The first group (two female, four male, age 27.5 ± 6.2 years mean) represented patients that were operated on MRI-negative FLE before installation of the intraoperative 1.5 T-MRI in 2002. The second group consisted of patients with MRI-negative, nonlesional epilepsy (four female seven male, age 30.1 ± 12.5 years mean) who underwent surgery using iopMRI and neuronavigation. The third group included eleven patients (eight female, three male, age 33.9 ± 11.7 years mean) with clear lesions as determined by preoperative MRI, and who underwent surgery with the aid of iopMRI and neuronavigation, as well. Demographic and clinical data of the patients are presented in Tables 1A and 1B. The mean overall preoperative duration of pharmacoresistant epilepsy was 16.1 ± 11.1 years (group 1: 16.4 ± 9.8, group 2:15.9 ± 12.3, group 3: 22.3 ± 16.2). Patients were followed up over an average of 70.3 months (from 12 to 284 months) after surgery. In three patients, MEG localization was inconclusive and contributed only partially to surgical planning (Tables 1A and 1B) .
Amount of resection and histology
We achieved a complete resection of the defined EZ including the MEG localization in 24/28 patients as documented by intraoperative MRI and/or late MRI at least 6 months after hospital discharge. In the first group, patient No. 2 was resected incompletely and was free of seizures for 6 months. He underwent second resective surgery 4.5 years later. Patient No. 5 underwent multiple subpial transections only. In the second group, intraoperative MRI revealed that the epileptic MEG localization was only resected partially in patients No. 8 and 13, which led to an update of neuronavigation and re-resection with complete removal of the defined EZ in both patients. Patient No. 17 was resected incompletely because of the EZ extended to the postcentral gyrus and the medial longitudinal fissure. In the third group, late postoperative MRI showed minimal residual parts of the cortical dysplasia in patient No. 28. Regarding the different treatment groups, a complete resection was achieved in 4/6 of the first group (67%), whereas 91% (10/11) of group two and three had total resections of the EZ each. Three subjects (No. 11, 12, 13) of the second group that had persistent seizures or even worsening of the seizure status were re-operated 9, 35 and 8 Fig. 1 . MSI localizations of interictal activity (average of n = 19 similar spikes) in patient No. 13. Yellow-red cloud represents the center-of-gravity of CLARA-source localization at the onset of the averaged spike pattern located in the right frontobasal paramedian hemisphere. Dipole result in red were calculated from the same interval (A). The patient was not seizure-free after the first operation. After performing another MEG (B), the waveform and amplitude distribution differed from the spikes shown in the previous figure. Consequently, the source analysis results also differ in localization and are more superior and posterior, suggesting a larger and extended epileptic network (average of n = 19 similar spikes). Blümcke et al. (2011) ; mMCD = mild variant of malformation of cortical development, ** classification according to Palmini et al. (2004) ; DNT = dysembryoblastic neuroepithelial tumor; # one patient underwent MST only; n = number of patients.
months after the first surgery (see Tables 1A and 1B) . Another three patients of group three had worsening of seizure status, of which one patient (No. 18) received a vagal nerve stimulator 31 months after first surgery. The results of the histopathologic examination are summarized in Table 2 . 
Seizure outcome
Tables 1A and 1B present seizure outcomes according to the different classes. Of 28 patients, 18 achieved excellent seizure control (Engel class IA, 64%) according to the most recent epilepsy outcome. The first group, 3/6 patients were seizure-free, whereas in the non-lesional second group, 7/11 had complete seizure control (64%). Patients with lesional FLE (group 3) were seizure-free in 8/11. Class I was achieved in 68% (19/28).
In 21% (6/28), we found a poor outcome. Three patients belonged to group two: one patient with persistent seizures after first surgery (Engel IIIA) and a worsened seizure status after second surgery, which we performed 8 months later (Engel IVA) . Of the other two patients with unsuccessful first surgery, No. 11 was re-operated 9 months later and achieved a complete seizure control (conversion from Engel IVA to IA) with a follow-up of 33 months. The other patient (No. 17) had longer intervals of seizure occurrence (IIIB) and was scheduled for re-operation 35 months later. She had a worthwhile improvement of seizure control (Engel IIIA) .
In group three, two patients had persistent seizures (Engel IIIA and B) , or even an aggravation of seizure frequency (Engel IVC) .
Five year follow-up data were available from 13 patients, of which eight had Engelís class IA seizure outcome (62%, Tables 1A and 1B). Comparison of seizure outcome regarding histopathology is presented in Table 2 .
Contribution of multimodal imaging qualities
Regarding post-operative transient and permanent neurological deficits, phase-2 diagnostics with cortical mapping, functional neuronavigation and intraoperative MR imaging resulted in transient deficit rate of 7.7% (1/13) and permanent in 2/13 (15.4%) patients. These subjects (patient No. 10, 22, 27) had either MEG localizations or lesions in the vicinity eloquent brain areas, which means that is was below the mean minimal distance measured (5.6 ± 5.9 mm) using the "ruler"-function of the navigation software.
Comparison of applied diagnostic techniques to identify the EZ and their congruence is presented in Table 3 . It shows that in cases with non-lesional epilepsy, MEG localizations matched with phase II, ECoG and ictal SPECT results in over 90% of all cases.
Case examples
Two case examples are given to further illustrate and emphazise our approach. Patient No. 20 is a straightforward case, where intraoperative MRI detected in incomplete resection of MEG localizations, which led to re-resection and complete removal of the MEG localizations and resulted in excellent seizure control (Fig. 4. ) Patient No. 13 is a 25-year-old male who suffers from drug-resistant FLE since the age of 20. He experienced focal seizures with impairment of consciousness up to a frequency of 20/day. EEG showed 
Table 3
Congruence of epileptogenic zone localization between MEG and other imaging techniques. group 1 (n = 6) group 2 (n = 11) group 3 (n = 11) overall (n = 28) left frontal spikes and spike-wave activity, voxel-based morphometry suspected a dysplasia near the orbital gyrus. MEG showed localizations fronto-orbital and fronto-mesial (Fig. 1) nearby the suspected VBM lesion. Ictal SPECT and Phase 2 monitoring consisting of subdural grids and depth electrodes confirmed a left frontal ictal onset zone. Surgery was performed with the aid of intraoperative ECoG using subdural strips and a depth electrode, which was placed within the fronto-basal MEG localizations. The intraoperative ECoG results revealed ictal activity at the basal and lateral MEG localizations, leading to a tailored resection of the fronto-basal cortex as well as approximately 2 cm anterior of Brocaís area as displayed using functional neuronavigation (Fig. 2) . Intraoperative MRI revealed complete resection of the MEG localizations and the defined area (Fig. 3) . We marked brain tissue lying within the MEG localizations intraoperatively, and histopathological examination revealed a FCD type IIa, which was located at the fronto-lateral part of the resection border. Unfortunately, the patient had persistent seizures, which appeared with lower frequency (2/week), which were mainly somatosensory auras. Due to the histopathological examination, we suspected that the FCD extended beyond the resected frontolateral area, causing persistant seizures. Second MEG examination revealed spikes at the superior margin of the resection cavity nearby the suspected residual FCD zone, which was adjacent to speech areas. At the re-operation, we re-segmented the suspected lesion according to the results of voxel-based morphometry, the fronto-lateral and basal margin including the remaining rectal gyrus using our neuronavigation software. Again, recent functional neuronavigation data including Brocaís area as well as the arcuate fascicle were used for intraoperative guidance. However, ECoG could not performed due to the pronounced adhesion of the dura mater and the cortex at the fronto-lateral part. Here, we resected the segmented area subpially. Intraoperative MRI revealed a complete resection of the segmented area. This time, histopathological investigation revealed chronical encephalitis with reactive astrogliosis. Follow up MRI scans, however, revealed a residual lesion within the Brocaís area. The patient was not seizure-free, which is most probably due still incomplete resection, which was related to high risk of permanent neurological deficits.
Complications and neurological outcome
There were three surgery-associated complications in this series (3/28, 11%). Patient No. 10 had a postoperative abacterial meningitis and a hygroma. The infection was treated with i.v. antibiotics and resolved completely after 14 days. The hygroma presented with a Brocaís aphasia (see below) and disappeared within 4 weeks after the operation without any new neurological deficits. Patient No. 24 had a wound infection which required i.v. antibiotics. A subgalean leakage of cerebrospinal fluid led to the implantation of a ventriculo-peritoneal shunt 15 days after epilepsy surgery in patient No. 26.
Six patients suffered from early postoperative seizures with the first week after surgery. In one patient (No. 9), the tonic-clonic seizure with loss of consciousness led to a head injury with a cut above the eyebrow, which was sutured.
Two patients (No. 2 and 10, 7.1%) had mild transient neurological deficits (difficulties in finding words, Brocaís aphasia), which resolved until discharge from hospital.
Another two patients (7.1%) suffered from permanent neurological deficits: a slight acalculia and dysgraphia together with word finding disabilities (patient No. 22) and a mild hemiparesis (patient No. 27) . No severe neurological deficits were present in this series.
Discussion
To our knowledge, this series demonstrates and compares the application of neuronavigational guidance and multimodal functional imaging in lesional and non-lesional drug resistant FLE patients using intraoperative MRI resection control for the first time. The key aspects include that MEG localization was congruent with invasive EEG and Phase-I modalities in over 80% in both patient groups. Intraoperative MRI and neuronavigation led to a complete removal of the MEG localizations in 91%, which resulted in not only a comparable but outstanding seizure control rate of 61% and 64% in both groups even after a long postoperative followup. Despite the lack of large patient numbers of each group, our intention to include patients treated in the pre-iopMRI and neuronavigation era in this analysis was to present a counterweight to the meaning and purpose of using new technologies in this surgical field.
The main difficulties that are encountered while treating drug-resistant frontal lobe epilepsy are the determination and interpretation of electro-clinical findings. The definition of the epileptogenic zone by EEG is often unclear due to the size of the affected brain area, the rapid propagation to the deeper brain structures, or involvement of large networks that are inaccessible to standard scalp EEG (Lee et al., 2008; Ossenblok et al., 2007; Stefan et al., 2011) . Another major problem is the vicinity of eloquent brain areas, which restrict surgery and lead to an incomplete resection, which is known as an unfavorable predictor of seizure control (Mu et al., 2014; Jeha et al., 2007; Téllez-Zenteno et al., 2005) . Furthermore, the absence of a clearly defined lesion in MRI corresponds to a poorer outcome after epilepsy surgery in those patients (Lazow et al., 2012; Simasathien et al., 2013; Wu et al., 2013) .
Especially in those patients with undetectable lesions in MRI, MEG studies can give additional clues concerning the localization of the epileptogenic region and subsequently, the extent of resection (Valdera et al., 2013; Wu et al., 2013) . The sensitivity for detection of interictal epileptic activity in focal epilepsies using MEG analysis lies around 70-80% and underlines the complimentary use of this modality for localization of the epileptogenic zone (Knowlton, 2008; Stefan et al., 2003) . The specificity of MEG to predict the seizure onset zone compared to intracranial EEG lies between 73% and 90% (Medvedovsky et al., 2012) . A recently published retrospective analysis revealed complete seizure freedom in 51% of 132 patients who underwent surgery with the aid of MEG, overlooking a mean follow-up of 3.6 years. Of those, 27 (21%) had FLE, and 59% of these patients achieved an Engel Class I outcome (Englot et al., 2015) . Furthermore, MEG localization seems particularly useful in patients with MRI-negative FCD, especially in the frontal lobe (Stefan et al., 2011; Wilenius et al., 2013) .
Thus, the resection of the hypothetical epileptogenic zone (EZ) should include the MEG cluster (Fischer et al., 2005) . To achieve a complete resection of the estimated EZ, we implemented presurgical MEG data into our surgical plan using neuronavigation and performed intraoperative MRI imaging to get immediate feedback on the resection extent. Comparison of diagnostic techniques to identify the EZ presurgically or intraoperatively revealed that in our series, MEG matched phase-II monitoring, ECoG and ictal SPECT results in over 90% in non-lesional and over 80% in lesional cases. Thus, MEG aided in determination and achieving complete resection in 89% (24/27), excluding one patient who underwent multiple subpial transsections (patient No. 5). As incomplete resections can occur because of the proximity to eloquent brain areas, we furthermore included functional MRI data and tractography in those cases. We have reported on our experience using multimodal navigation in patients with extratemporal epilepsy before, where the site of resection was located nearby or within eloquent brain areas (Sommer et al., 2013) . The benefit of an intraoperative resection control lies not only in maximizing the extent of resection, but also in minimizing postoperative neurological deficits. Our complication and risk ratios were equal and in some cases even better than the reported numbers of the literature, which underlines our concept of non-invasive functional imaging in contrast to the concept of awake surgery with direct cortical stimulation. Seizures provoked by direct cortical stimulation can lead to a false interpretation of ECoG patterns and result in insufficient functional mapping, which is particularly of concern in epilepsy surgery (Nossek et al., 2013; Morace et al., 2012) .
In this retrospective analysis, we compared seizure control, neurological outcome and extent of resection of three patients groups. Due to the small case load and different MEG system used, however, we considered group one separately. Here, four out of six patients (60%) who suffered from MRI-negative FLE who were operated on without the use of multimodal navigation had a complete resection of the MEG localizations as documented by late MRI.
On the other hand, in both group two with MRI-negative FLE and group three with lesional FLE a rate of 91% was achieved. Intraoperative MRI showed incomplete resection of the MEG localizations in four patients (18%, two in each group), and re-resection lead two complete removal in all four patients. With two of those four were seizure-free to date might give a hint of the potential benefit of iopMRI and implementation of MEG data during epilepsy surgery. This observation is part of work in progress, and the second case example highlights the difficulties when MEG localizations were out of the resection volume despite applying sophisticated technology.
In general, seizure control is not as favourable in FLE than in TLE, and even less successful in MRI-negative cases. A systematic review of 158 drug-resistant lesional FLE patients operated on in the Cleveland Clinic revealed a 4-year seizure-free rate (Engel IA) of 50% (Simasathien et al., 2013) . A large meta-analysis by Téllez-Zenteno et al. (2005) revealed that from 7269 patients (with exclusion of multiple subpial transsections), the rate of frontal lobe epilepsy operation was 6.9% (486 patients). Of those, only 27% were completely seizure-free.
There are only few reports on MRI-negative patients suffering from drug-resistant FLE who had preoperative MEG to date. Studies revealed an Engel class I seizure control between 30 and 58% Lazow et al., 2012; Wilenius et al., 2013) . Complete seizure freedom was achieved in 25% (Cascino et al., 1992) and 66% (Wu et al., 2013 ) of MRI-negative FLE patients, down to none of the patients after an observation period of three years (Jeha et al., 2007) .
In our study, an excellent seizure control (Engel IA) was achieved in 64% of all patients. In thirteen patients, long-term follow up (>5 yrs) was available, and eight out of those (62%) were seizure-free. Group comparison revealed that complete seizure control (Engel IA) rates of the non-lesional and lesional groups operated on with multimodal neuronavigation and iopMRI were similar (7/11 and 8/11). Even in the first group which was operated on non-lesional FLE without having neuronavigation and iopMRI at hand, an Engel class IA outcome was achieved in 50%. Although the sample sizes are too small for group comparisons, this should point to the fact that presurgical work-up and planning as well as patient selection cannot be valued too high. Thus, seizure control is not only remarkable in our series, but our data indicate that even in non-lesional FLE, multimodal imaging could raise the rate of complete resections and seizure freedom up to a level which is only seen in lesional FLE.
Regarding functional outcome related to FLE surgery, there are only few studies that report on surgery-associated neurological deficit rates. In 8% to 27% of cases, a transient deficit and in 1% to 5%, a permanent deficit was reported (Elsharkawy et al., 2008b; PondalSordo et al., 2006; Schramm et al., 2002) . Considering our transient deficit rate of 12% and a mild permanent neurological deficit in one patient (6%), our multimodal approach seems to be not inferior in this well-selected, difficult to treat epilepsy cohort. Postoperative complications were seen in two patients (12%), which included a urinary tract infection and a hygroma.
Future directions
The expansion of using other diagnostic methods such as PET or SPECT or even non-invasive blood flow and metabolism measurement techniques in MRI-negative epilepsy is considered as another step towards defining the potential epileptogenic zone. An emphasis is laid on the fact that these methods as well as EEG and MEG ought to be used complimentary in such difficult cases (Rheims et al., 2013) . In the future, we are planning to further evaluate the contribution of these diagnostic tools and to refine their integration into our intraoperative navigation system. Our vision is that in selected cases, MEG can contribute to presurgical evaluation of the EZ to such a degree that the need for invasive diagnostics could be reduced to a minimum.
Limitations of this retrospective investigation
One important limiting factor is the small sample size in this patient cohort and the selection bias that is associated with the three different groups. This makes a statistic calculation and substantial comparison of our results within the three different groups impossible. Despite being a referral University Hospital for epilepsy surgery in Germany, only 22% of patients identified with FLE were ill-defined or MRI-negative. This low rate is comparable to the results of a meta-analysis including 1199 patients by Englot et al. (2012) , who reported on a rate of 20.4% of normal MRI scans. Since our strategy of "multimodal imaging" has been applied in about 450 epilepsy surgery cases since 2002, our low case load describes the actual condition of an epilepsy surgery center. However, our remarkable results once more underline the necessity of careful patient selection and accurate indication of medical treatment, which leads to a diminishing number of eligible patients.
This major obstacle is one reason for another limitation of our work, the lack of a prospective, randomized controlled trial to compare intraoperative MRI and neuronavigation with standard surgical procedures. The difficulties to conduct well-powered randomized controlled trials is clearly documented by the Early Randomized Surgical Epilepsy Trial (ERSET), which was aborted due to slow patient enrollment (Engel et al., 2012) . From the beginning of this trial, a major obstacle was the primary referral of patients to specialist epilepsy centers. Of 76 patients screened for eligibility, thirteen were excluded because of normal MR and PET imaging results. A recently published review article by Sovenso et al. (2015) underlines the need for prospective, well-designed studies to provide the efficiacy and safety of intraoperative neuronavigation in epilepsy surgery. Keeping in mind the small case load of our series, further validation of a statistically significant better seizure control in patients where intraoperative MRI contributed to a higher rate of complete resection of MEG localizations is necessary. Despite these issues, we would have had to justify the refusal of an available sophisticated, modern technology such as multimodal neuronavigation to have controls before the patients and the local ethical board.
Using neuronavigation contains many inaccuracies, including brain shift. We updated neuronavigation data using the intraoperative post-resection MR images to compensate the shifting of brain structures and functional data including fiber tracts. Depending on the size of the resection cavity and its location, the error of the navigation system can be diminished (Sommer et al., 2013) .
Conclusions
Drug-resistant frontal lobe epilepsies that have no visible lesion on MR imaging are one of the subgroups of difficult-to-treat epilepsies. They present a challenge for the epileptologist as well as for the surgeon. Despite the unclear nature of the presumed epileptogenic area, one imaging modality that can contribute to a better seizure control in those patients is MEG. The combination of invasive EEG monitoring, MEG-guided resection using neuronavigation and iopMRI resection control led to promising results, which are comparable to seizure control rates achieved in patients with lesional FLE. Complimentary use of additional imaging qualities could compensate the problem of setting limits to ill-defined or obscure epileptogenic zones.
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